An Adaptable Platform for in-house Hepatitis C Serology

This study provides a thorough description of the development, and validation of a multiepitope ELISA-based diagnostic assay against HCV, which could be implemented at low cost. The described methodology can be readily adapted to develop novel ELISA-based diagnostic assays for other infectious pathogens with well-described immunogenic epitopes. This method could improve the diagnosis of neglected diseases for which affordable diagnostic assays are lacking.PMID:35850366 | DOI:10.1016/j.jviromet.2022.114586

Source: Journal of Virological Methods - July 19, 2022 Category: Virology Authors: Jannie Pedersen Ir ène Pegha Moukandja Stella Ndidi Anna-Louise S ørensen Isma ël Hervé Koumakpayi Jean-Bernard Lekana-Douki Marie-Louise Vachon Nina Weis Gary Kobinger Hugues Fausther-Bovendo Source Type: research